Skip to main content
. 2017 Apr 25;2017(4):CD003200. doi: 10.1002/14651858.CD003200.pub7
Methods RCT, 4 parallel arms
Participants Diagnostic criteria: CDC 1994
Number of participants: N = 114
Gender: 95 (83.3%) female
Age: 43.8 years
Earlier treatment: NS
Co‐morbidity: 44 (39%) with a current Axis I disorder (depression and anxiety most common). Use of antidepressant not stated
Illness duration: > 5 years
Work and employment status: 52 (46%) working or studying at least part time, 24% unemployed, 6% retired, 25% on disability
Setting: secondary care, but recruitment from different sources
Country: USA
Interventions 13 sessions every 2 weeks lasting 45 minutes
Group 1: cognitive‐behavioural therapy (CBT) aimed at showing participants that activity could be done without exacerbating symptoms (n = 29)
Group 2: anaerobic activity therapy (ACT) focused on developing individualised and pleasurable activities accompanied by reinforcement of progress (n = 29)
Group 3: cognitive therapy treatment(COG) focused on developing strategies to better tolerance, reduce stress and symptoms and lessen self‐criticism (n = 28)
Group 4: relaxation treatment (RELAX) introducing several types of relaxation techniques along with expectations of skill practice (n = 28)
Outcomes Several outcomes are reported (˜25), among others.
  • Physical functioning (SF‐36)

  • Fatigue (Fatigue Severity Scale, FSS)

  • Depression (Back Depression Inventory, BDI‐II)

  • Anxiety (Beck Anxiety Inventory, BAI)

  • Self‐efficacy (self‐efficacy questionnaire)

  • Stress (Perceived Stress Scale, PSS)

  • Pain (Brief Pain Inventory)

  • Quality of life (Quality of Life Scale)

  • 6‐Minute walking test


Outcomes assessed at 12 months' follow‐up
Notes Fidelity ratings and drop‐out reported across study arms
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Random assignment was done using a random number generator in statistical software (SPSS version 12)"
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection bias) of participants and personnel? High risk Not possible to blind participants or personnel (supervisors) to treatment allocation
Blinding (performance bias and detection bias) of outcome assessors? High risk Blinding not possible for self‐reported measurements (e.g. FSS, BPI)
Incomplete outcome data (attrition bias) All outcomes High risk Quote: "The average dropout rate was 25%, but it was not significantly different per condition." The statistical analysis used, the best linear unbiased predictor, is a way to avoid taking missing data into account
Selective reporting (reporting bias) Unclear risk All primary outcomes stated under Methods were reported; however, as the trial protocol is not available, we cannot categorically state that the review is free of selective outcome reporting
Other bias High risk Baseline data differences across groups for several important parameters (e.g. physical functioning: ACT group 39.17 (15.65) and RELAX group 53.77 (26.66))